The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases
Open accessAbstract
The study of antiviral pathways to reveal methods for the effective response and clearance of virus is closely related to understanding interferon (IFN) signaling and its downstream target genes, IFN-stimulated genes. One of the key antiviral factors induced by IFNs, 2′-5′ oligoadenylate synthase (OAS), is a well-known molecule that regulates the early phase of viral infection by degrading viral RNA in combination with RNase L, resulting in the inhibition of viral replication. In this review, we describe OAS family proteins from a different point of view from that of previous reviews. We discuss not only RNase L-dependent (canonical) and -independent (noncanonical) pathways but also the possibility of the OAS family members as biomarkers for various diseases and clues to non-immunological functions based on recent studies. In particular, we focus on OASL, a member of the OAS family that is relatively less well understood than the other members. We will explain its anti- and pro-viral dual roles as well as the diseases related to single-nucleotide polymorphisms in the corresponding gene.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interferon-inducible antiviral effectors
Sadler, A. J., & Williams, B. R. G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2314 · Cited by 2,160
Mostashari, F., Bunning, M. L., Kitsutani, P. T., Singer, D. A., Nash, D., Cooper, M. J., Katz, N., Liljebjelke, K. A., Biggerstaff, B. J., Fine, A. D., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05480-0 · Cited by 657
New Insights into the Role of RNase L in Innate Immunity
Chakrabarti, A., Jha, B. K., & Silverman, R. H. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0120 · Cited by 314
Constitutive expression of (2′–5′) oligo A synthetase confers resistance to picornavirus infection
Chebath, J., Benech, P., Revel, M., & Vigneron, M. (1987) · Nature · doi:10.1038/330587a0 · Cited by 273
Antiviral Activity of Human OASL Protein Is Mediated by Enhancing Signaling of the RIG-I RNA Sensor
Zhu, J., Zhang, Y., Ghosh, A., Cuevas, R. A., Forero, A., Dhar, J., Ibsen, M. S., Schmid-Burgk, J. L., Schmidt, T., Ganapathiraju, M. K., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.05.007 · Cited by 272
Rebouillat, D., & Hovanessian, A. G. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313992 · Cited by 232
Knapp, S., Yee, L. J., Frodsham, A. J., Hennig, B. J. W., Hellier, S., Zhang, L., Wright, M., Chiaramonte, M., Graves, M., Thomas, H. C., et al. (2003) · Genes & Immunity · doi:10.1038/sj.gene.6363984 · Cited by 220
Lin, R.-J., Yu, H.-P., Chang, B.-L., Tang, W.-C., Liao, C.-L., & Lin, Y.-L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902728 · Cited by 200
Tsai, M.-H., Cook, J. A., Chandramouli, G. V. R., DeGraff, W., Yan, H., Zhao, S., Coleman, C. N., Mitchell, J. B., & Chuang, E. Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4250 · Cited by 200
The role of 2′-5′ oligoadenylate-activated ribonuclease L in apoptosis
Castelli, J. C., Hassel, B. A., Maran, A., Paranjape, J., Hewitt, J. A., Li, X.-L., Hsu, Y.-T., Silverman, R. H., & Youle, R. J. (1998) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400352 · Cited by 181
Anticellular and antiviral effects of pppA(2′p5′A)n
Hovanessian, A. G., & Wood, J. N. (1980) · Virology · doi:10.1016/0042-6822(80)90485-7 · Cited by 159
Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase.
Dong, B., Xu, L., Zhou, A., Hassel, B. A., Lee, X., Torrence, P. F., & Silverman, R. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36767-4 · Cited by 157
Bonnevie‐Nielsen, V., Field, L. L., Lu, S., Zheng, D., Li, M., Martensen, P. M., Nielsen, T. B., Beck‐Nielsen, H., Lau, Y., & Pociot, F. (2005) · The American Journal of Human Genetics · doi:10.1086/429391 · Cited by 155
Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer
Wang, S., González, P., Yu, K. F., Porras, C., Li, Q., Safaeian, M., Rodríguez, A. C., Sherman, M. E., Bratti, C., SCHIFFMAN, M. H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008667 · Cited by 154
Dengue Virus Induces Novel Changes in Gene Expression of Human Umbilical Vein Endothelial Cells
Warke, R. V., Xhaja, K., Martin, K. J., Fournier, M. V., Shaw, S. K., Brizuela, N., de Bosch, N., Lapointe, D. S., Ennis, F. A., Rothman, A. L., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.21.11822-11832.2003 · Cited by 151
OASL1 inhibits translation of the type I interferon–regulating transcription factor IRF7
Lee, M. S., Kim, B., Oh, G. T., & Kim, Y.-J. (2013) · Nature Immunology · doi:10.1038/ni.2535 · Cited by 143
Self-citationYakub, I., Lillibridge, K. M., Moran, A., Gonzalez, O. Y., Belmont, J. W., Gibbs, R. A., & Tweardy, D. J. (2005) · The Journal of Infectious Diseases · doi:10.1086/497340 · Cited by 131
Bréhin, A., Casadémont, I., Frenkiel, M., Julier, C., Sakuntabhai, A., & Desprès, P. (2008) · Virology · doi:10.1016/j.virol.2008.10.021 · Cited by 123
Kristiansen, H., Scherer, C., McVean, M., Iadonato, S. P., Vends, S., Thavachelvam, K., Steffensen, T. B., Horan, K., Kuri, T., Weber, F., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01003-10 · Cited by 119
Middelberg, R. P. S., Ferreira, M. A. R., Henders, A. K., Heath, A. C., Madden, P. A. F., Montgomery, G. W., Martin, N. G., & Whitfield, J. B. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-123 · Cited by 114
Differential Regulation of the OASL and OAS1 Genes in Response to Viral Infections
Melchjorsen, J., Kristiansen, H., Christiansen, R., Rintahaka, J., Matikainen, S., Paludan, S. R., & Hartmann, R. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0050 · Cited by 113
Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family
Eskildsen, S. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg427 · Cited by 112
Kajaste‐Rudnitski, A., Mashimo, T., Frenkiel, M., Guénet, J., Lucas‐Hourani, M., & Desprès, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508649200 · Cited by 109
Sanayama, Y., Ikeda, K., Saito, Y., Kagami, S., Yamagata, M., Furuta, S., Kashiwakuma, D., Iwamoto, I., Umibe, T., Nawata, Y., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38400 · Cited by 105
He, J., Feng, D., de Vlas, S. J., Wang, H., Fontanet, A. L., Zhang, P., Plancoulaine, S., Tang, F., Zhan, L., Yang, H., et al. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-106 · Cited by 101
Hovnanian, A., Rebouillat, D., Mattéi, M., Levy, E. R., Marié, I., Monaco, A. P., & Hovanessian, A. G. (1998) · Genomics · doi:10.1006/geno.1998.5443 · Cited by 95
Ibsen, M. S., Gad, H. H., Thavachelvam, K., Boesen, T. P., Desprès, P., & Hartmann, R. (2014) · Journal of Virology · doi:10.1128/jvi.01763-14 · Cited by 91
Barkhash, A. V., Perelygin, A. A., Babenko, V. N., Myasnikova, N. G., Иванович, П. П., Romaschenko, A. G., Voevoda, M. I., & Brinton, M. A. (2010) · The Journal of Infectious Diseases · doi:10.1086/657418 · Cited by 90
Marques, J. T., Anwar, J., Eskildsen-Larsen, S., Rebouillat, D., Paludan, S. R., Sen, G. C., Williams, B. R. G., & Hartmann, R. (2008) · Journal of General Virology · doi:10.1099/vir.0.2008/003558-0 · Cited by 74
Ghosh, A., Sarkar, S. N., Guo, W., Bandyopadhyay, S., & Sen, G. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.33220 · Cited by 71
Mullan, P. B., Hosey, A. M., Buckley, N. E., Quinn, J. E., Kennedy, R. D., Johnston, P. G., & Harkin, D. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208698 · Cited by 60
Kwon, Y.-C., Kang, J.-I., Hwang, S. B., et al. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.11.010 · Cited by 59
Self-citationLee, M. S., Park, C. H., Jeong, Y. H., Kim, Y., & Ha, S. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003478 · Cited by 54
Self-citationGene structure of the murine 2′-5′-oligoadenylate synthetase family
Eskildsen, S., Hartmann, R., Kjeldgaard, N. O., & Justesen, J. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8499-2 · Cited by 53
Courtney, S. C., Di, H., Stockman, B. M., Liu, H., Scherbik, S. V., & Brinton, M. A. (2012) · Journal of Virology · doi:10.1128/jvi.00333-12 · Cited by 51
Role of mitochondria in apoptosis induced by the 2‐5A system and mechanisms involved
Domingo-Gil, E., & Estéban, M. (2006) · APOPTOSIS · doi:10.1007/s10495-006-5541-0 · Cited by 50
(2′-5′)Oligoadenylate and intracellular immunity against retrovirus infection
Schröder, H. C., Suhadolnik, R. J., Pfleiderer, W., Charubala, R., & Müller, W. E. G. (1992) · International Journal of Biochemistry · doi:10.1016/0020-711x(92)90229-t · Cited by 50
Gad, H. H., Paulous, S., Belarbi, E., Diancourt, L., Drosten, C., Kümmerer, B. M., Plate, A. E., Caro, V., & Desprès, P. (2012) · Virology · doi:10.1016/j.virol.2012.07.019 · Cited by 46
Type 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype?
Tessier, M.-C., Qu, H.-Q., Fréchette, R., Bacot, F., Grabs, R., Taback, S. P., Lawson, M. L., Kirsch, S. E., Hudson, T., & Polychronakos, C. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.035212 · Cited by 46
Alagarasu, K., Honap, T. P., Damle, I. M., Mulay, A. P., Shah, P. S., & Cecilia, D. (2013) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2012.12.021 · Cited by 40
Possible involvement of (2'5')oligoadenylate synthetase activity in pre-mRNA splicing.
Sperling, J. M., Chebath, J., Arád-Dann, H., Offen, D., Spann, P., Lehrer, R., Goldblatt, D., Jollès, B., & Sperling, R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10377 · Cited by 39
Bordignon, J., Probst, C., Mosimann, A. L. P., Pavoni, D. P., Stella, V., Buck, G. A., Satproedprai, N., Fawcett, P., Zanata, S. M., de Noronha, L., et al. (2008) · Virology · doi:10.1016/j.virol.2008.04.033 · Cited by 37
Hovnanian, A., Rebouillat, D., Levy, E. R., Mattéi, M., & Hovanessian, A. G. (1999) · Genomics · doi:10.1006/geno.1998.5737 · Cited by 28
Andersen, J. B., Strandbygaard, D., Hartmann, R., & Justesen, J. (2004) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03966.x · Cited by 25
Zhou, Y., Kang, M., Jha, B. K., Silverman, R. H., Lee, C. G., & Elias, J. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300082 · Cited by 23
Croze, E. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0022 · Cited by 19
Almeida, G. M. D. F., de Oliveira, D. B., Botelho, L. M., Silva, L. K. D. S., Guedes, A. C. M., Santos, F. P. S. T., Bonjardim, C. A., Ferreira, P. C. P., & Kroon, E. G. (2013) · Autoimmunity · doi:10.3109/08916934.2013.866102 · Cited by 16
Identification of OASL d, a splice variant of human OASL, with antiviral activity
Guo, X., Li, X., Xu, Y., Sun, T., Yang, G., Wu, Z., & Li, E. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.04.001 · Cited by 14
Cited by
Genetic mechanisms of critical illness in COVID-19
The GenOMICC Investigators, Pairo-Castineira, E., The ISARIC4C Investigators, Initiative, T. C.-1. H. G., 23andMe Investigators, BRACOVID Investigators, Gen-COVID Investigators, Clohisey, S., Klaric, L., Bretherick, A. D., et al. (2021) · Nature · doi:10.1038/s41586-020-03065-y · Cited by 1,365
Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection
East-Seletsky, A., O’Connell, M. R., Knight, S. C., Burstein, D., Cate, J. H. D., Tjian, R., & Doudna, J. A. (2016) · Nature · doi:10.1038/nature19802 · Cited by 1,236
Di Giorgio, E., & Xodo, L. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.917998 · Cited by 39
Metadata
- Authors
- Choi, U. Y., Kang, J.-S., Hwang, Y. S., & Kim, Y.-J.
- Venue
- Experimental & Molecular Medicine
- Published
- 2015-03-06
- Volume
- 47
- Issue
- 3
- Pages
- e144-e144
- ISSN
- 1226-3613 (ISSN-L)
- 2092-6413
- OpenAlex
- W2069310363
- Cited by
- 254
- References
- 48
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.